85 related articles for article (PubMed ID: 17974423)
1. [Intercellular adhesion molecule-1 expression in renal cell carcinoma].
Brasanac D; Radotić-Smiljanić K; Basta-Jovanović G; Tatić S; Marković-Lipkovski J
Srp Arh Celok Lek; 1995; 123(7-8):177-9. PubMed ID: 17974423
[TBL] [Abstract][Full Text] [Related]
2. Immunomorphological characteristics of renal cell carcinoma.
Markovic-Lipkovski J; Brasanac D; Todorovic V; Müller CA; Müller GA
Histol Histopathol; 1995 Jul; 10(3):651-9. PubMed ID: 7579814
[TBL] [Abstract][Full Text] [Related]
3. [Histogenesis of renal cell carcinoma].
Brasanac D; Todorović V; Knezević-Usaj S; Markovic-Lipkovski J
Med Pregl; 1996; 49(1-2):23-5. PubMed ID: 8643065
[TBL] [Abstract][Full Text] [Related]
4. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
5. The evolution of collagen expression in sarcomatoid renal cell carcinoma.
Delahunt B; Bethwaite PB; McCredie MR; Nacey JN
Hum Pathol; 2007 Sep; 38(9):1372-7. PubMed ID: 17521699
[TBL] [Abstract][Full Text] [Related]
6. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications.
Ozcan A; Shen SS; Zhai QJ; Truong LD
Am J Clin Pathol; 2007 Aug; 128(2):245-54. PubMed ID: 17638658
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic properties of renal cell carcinoma and the pathogenesis of osteolytic bone metastases.
Perut F; Cenni E; Unger RE; Kirkpatrick CJ; Giunti A; Baldini N
Int J Oncol; 2009 May; 34(5):1387-93. PubMed ID: 19360351
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
[TBL] [Abstract][Full Text] [Related]
9. The utility of Pax-2 as an immunohistochemical marker for renal cell carcinoma in cytopathology.
Gokden N; Kemp SA; Gokden M
Diagn Cytopathol; 2008 Jul; 36(7):473-7. PubMed ID: 18528893
[TBL] [Abstract][Full Text] [Related]
10. Expression of two isozymes of acyl-coenzyme A: cholesterol acyltransferase-1 and -2 in clear cell type renal cell carcinoma.
Matsumoto K; Fujiwara Y; Nagai R; Yoshida M; Ueda S
Int J Urol; 2008 Feb; 15(2):166-70. PubMed ID: 18269457
[TBL] [Abstract][Full Text] [Related]
11. Characterization of HLA-G expression in renal cell carcinoma.
Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
[TBL] [Abstract][Full Text] [Related]
12. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin expression in normal kidney tissue and renal carcinomas.
Dagli AF; Aydin S; Karaoglu A; Akpolat N; Ozercan IH; Ozercan MR
Pathol Res Pract; 2009; 205(3):165-73. PubMed ID: 19054628
[TBL] [Abstract][Full Text] [Related]
14. Expression of intercellular adhesion molecule-1 (ICAM-1) on renal-cell cancer: possible significance in host immune responses.
Tomita Y; Nishiyama T; Watanabe H; Fujiwara M; Sato S
Int J Cancer; 1990 Dec; 46(6):1001-6. PubMed ID: 1979067
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
16. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.
Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD
Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138
[TBL] [Abstract][Full Text] [Related]
17. Cell surface expression and serum levels of intercellular adhesion molecule-1 in renal cell carcinoma.
Heicappell R; Podlinski J; Buszello H; Ackermann R
Urol Res; 1994; 22(1):9-15. PubMed ID: 7915444
[TBL] [Abstract][Full Text] [Related]
18. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
19. Cellular expression of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 in normal kidney structures and in renal cancer. Possible significance in immune response and in the clinicopathological correlation.
Minervini R; Panichi V; Viganò L; Felipetto R; Gattai V; Cecchi M; Fiorentini L; Palla R
Eur Urol; 1994; 26(1):103-6. PubMed ID: 7925526
[TBL] [Abstract][Full Text] [Related]
20. S100 protein expression distinguishes metanephric adenomas from other renal neoplasms.
Azabdaftari G; Alroy J; Banner BF; Ucci A; Bhan I; Cheville JC
Pathol Res Pract; 2008; 204(10):719-23. PubMed ID: 18621486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
